Neurocrine Biosciences, Inc.

NasdaqGS: NBIX · Healthcare

Positivity Index

#4,071 / 6,775

Global

#1,926 / 4,000

United States

Positivity Score

19,975

Rank→

PosiRed: no active red flags · PosiYellow: 1 yellow flag (1/10 points) View flag history →

PosiYellow · yellow flag (stress signal)

Pledge-related SEC filings found

Found 4 SEC Form 4 filing(s) mentioning 'pledged' for this company's insiders. No exact percentage is available from this source (unlike India's BSE disclosures) — this flags that pledge-related activity exists and is worth reviewing directly on SEC EDGAR, not a computed magnitude.

More details →

Neurocrine Biosciences, Inc. — Overview & Financial Snapshot

Neurocrine Biosciences, Inc. (NasdaqGS: NBIX) is a Healthcare company, ranked #4,071 of 6,775 companies globally and #1,926 of 4,000 in United States on PositoAI, with a Positivity Score of 19,975. Its market capitalisation is ₹1.37 lakh Cr ($14.57B), P/E ratio is 21.0 and P/B ratio is 3.94. It has no active red flags (PosiRed) and 1 yellow flag (PosiYellow, 1/10 points): Pledge-related SEC filings found.

For financial statements, ratio trends and score history, Go Deep →

What does Neurocrine Biosciences, Inc. do?

Neurocrine Biosciences, Inc. discovers, develops, and commercialize pharmaceuticals for neurological, psychiatric, endocrine, and immunological disorders in the United States and internationally. The company's products include INGREZZA for tardive dyskinesia and chorea associated with Huntington's disease; Orilissa…

What is Neurocrine Biosciences, Inc.'s P/E and P/B ratio?

Neurocrine Biosciences, Inc. has a P/E ratio of 21.0 and a P/B ratio of 3.94.

What is Neurocrine Biosciences, Inc.'s debt-to-equity ratio?

Neurocrine Biosciences, Inc. has a debt-to-equity ratio of 0.12.

How much does Neurocrine Biosciences, Inc. owe compared with what it owns?

Neurocrine Biosciences, Inc. owes $0.31 for every $1 it owns (balance sheet Jun 2026), which is low.

What is Neurocrine Biosciences, Inc.'s Positivity rank?

Neurocrine Biosciences, Inc. is ranked #4,071 of 6,775 companies globally and #1,926 of 4,000 in United States on PositoAI, with a Positivity Score of 19,975.

Does Neurocrine Biosciences, Inc. have any regulatory orders, red flags (PosiRed) or yellow flags (PosiYellow)?

Neurocrine Biosciences, Inc. has no active red flags. It has 1 yellow flag (PosiYellow stress signals, 1/10 points): Pledge-related SEC filings found.

Where can I read the latest news about Neurocrine Biosciences, Inc.?

Recent headlines about Neurocrine Biosciences, Inc. from the last 30 days, with links to the original articles, are on its News page on PositoAI.

Does Neurocrine Biosciences, Inc. have a PositoAI PosiShot or QR code?

Yes. A dated PosiShot of Neurocrine Biosciences, Inc.'s current position, a PosiQR code for its live profile and a ready-made dated mention are available on its For this company page on PositoAI.